| scholarly article | Q13442814 |
| P50 | author | Andrzej S. Krolewski | Q87809680 |
| P2093 | author name string | Robert G Nelson | |
| Bruce A Perkins | |||
| Bryan D Myers | |||
| James H Warram | |||
| Kristina L Blouch | |||
| Betsy E P Ostrander | |||
| P2860 | cites work | Progression of overt nephropathy in non-insulin-dependent diabetes | Q46090183 |
| Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. | Q47226830 | ||
| Cystatin C--a new marker of glomerular filtration rate in children independent of age and height | Q47288949 | ||
| Predictive performance of ten equations for estimating creatinine clearance in cardiac patients. Iohexol Cooperative Study Group. | Q52228138 | ||
| Longitudinal studies on the rate of decline in renal function with age. | Q55061206 | ||
| Application of newer clearance techniques for the determination of glomerular filtration rate | Q57703944 | ||
| Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran | Q71305712 | ||
| Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group | Q71801740 | ||
| Mechanism of glomerular hyperfiltration after a protein meal in humans. Role of hormones and amino acids | Q72714200 | ||
| Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function | Q73044076 | ||
| Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults | Q73484343 | ||
| Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases | Q74138779 | ||
| Quantitative automated particle-enhanced immunonephelometric assay for the routinary measurement of human cystatin C | Q77758151 | ||
| Statistical methods for assessing agreement between two methods of clinical measurement | Q26778461 | ||
| Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis | Q28216384 | ||
| Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement | Q28256758 | ||
| K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification | Q29547560 | ||
| How to assess glomerular function and damage in humans | Q33547401 | ||
| Serum cystatin C as an endogenous marker of the renal function--a review | Q33658748 | ||
| Developments in the assessment of glomerular filtration rate | Q33936490 | ||
| Glomerular function in Pima Indians with noninsulin-dependent diabetes mellitus of recent onset | Q34193127 | ||
| Serum cystatin C as a marker of glomerular filtration rate | Q34331634 | ||
| Cystatin C. | Q34584709 | ||
| Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency | Q34609683 | ||
| Cystatin C: an improved estimator of glomerular filtration rate? | Q34616081 | ||
| Commentary: clinical diagnostic use of cystatin C. | Q35632596 | ||
| Natural history and pathogenesis of diabetic nephropathy | Q36911146 | ||
| How to protect the kidney in diabetic patients: with special reference to IDDM. | Q41585880 | ||
| Determination of serum cystatin C: biological variation and reference values | Q43767240 | ||
| Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients | Q43936733 | ||
| Goodpasture syndrome during the course of a Schönlein-Henoch purpura. | Q43973121 | ||
| Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance. | Q44195323 | ||
| A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate | Q44588682 | ||
| Comparative performance of serum cystatin-c versus serum creatinine in diabetic subjects | Q44606764 | ||
| Serum cystatin C assay for the detection of early renal impairment in diabetic patients. | Q44733550 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 1404-12 | |
| P577 | publication date | 2005-05-01 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study | |
| P478 | volume | 16 |
| Q36843484 | A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease. |
| Q45236215 | A possible role of cystatin C in adipose tissue homeostasis may impact kidney function estimation in metabolic syndrome |
| Q51356367 | Ability of Cystatin C to detect changes in glomerular filtration rate after ACE inhibition in patients with uncomplicated type 1 diabetes. |
| Q42831084 | Ability of cystatin C to detect acute changes in glomerular filtration rate provoked by hyperglycaemia in uncomplicated Type 1 diabetes |
| Q21558546 | Accuracy and limitations of equations for predicting the glomerular filtration rate during follow-up of patients with non-diabetic nephropathies |
| Q42251188 | Age and gender differences in the relationship between hepatitis C infection and all stages of Chronic kidney disease |
| Q35407916 | Age and sex influence cystatin C in adolescents with and without type 1 diabetes |
| Q31071745 | Antiphospholipid Antibodies and Renal Impairment Parameters in Diabetic Nephropathy: Preliminary Data |
| Q33562005 | Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study). |
| Q33932292 | Association of cystatin C with adverse outcomes. |
| Q24646339 | Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study |
| Q33357921 | Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA). |
| Q36667225 | Association of mild to moderate kidney dysfunction and coronary calcification |
| Q33617174 | Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the Heart and Soul Study |
| Q36666878 | Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics |
| Q34150807 | Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study |
| Q53740601 | Biomarker for early renal microvascular and diabetic kidney diseases. |
| Q38290083 | Biomarkers in diabetic nephropathy: Present and future |
| Q47914885 | Can admission serum cystatin C level be an early marker subclinical acute kidney injury in critical care patients? |
| Q35817069 | Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes |
| Q37477717 | Change in estimated GFR associates with coronary heart disease and mortality |
| Q26822369 | Chronic kidney disease screening methods and its implication for Malaysia: an in depth review |
| Q35804154 | Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes |
| Q37228758 | Clinical and subclinical cardiovascular disease and kidney function decline in the elderly |
| Q33608612 | Comparison of CKD-EPI Cystatin C and Creatinine Glomerular Filtration Rate Estimation Equations in Asian Indians |
| Q59050709 | Comparison of Different Measures of Fat Mass and Their Association with Serum Cystatin C Levels |
| Q37680650 | Comparison of estimated GFR equations based on serum cystatin C alone and in combination with serum creatinine in patients with coronary artery disease |
| Q43206247 | Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty. |
| Q41205172 | Correlation between cystatin C-based formulas, Schwartz formula and urinary creatinine clearance for glomerular filtration rate estimation in children with kidney disease |
| Q37859381 | Correlation of estimated and measured glomerular filtration rate in patients with interposed bowel in the urinary tract. |
| Q92663850 | Creatinine- and cystatin C-based estimated glomerular filtration rate slopes for the prediction of kidney outcome: a comparative retrospective study |
| Q36976287 | Cystatin C as a marker of cognitive function in elders: findings from the health ABC study |
| Q34457290 | Cystatin C identifies chronic kidney disease patients at higher risk for complications |
| Q24635177 | Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study |
| Q35189962 | Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons |
| Q55042196 | Cystatin C, kidney function and cardiovascular disease. |
| Q31067194 | Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study |
| Q36869663 | Cystatin C--a paradigm of evidence based laboratory medicine. |
| Q37856794 | Cystatin C: a step forward in assessing kidney function and cardiovascular risk |
| Q37313436 | Cystatin C: current position and future prospects |
| Q37112901 | Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration |
| Q40479177 | Cytokine Profile in Calcineurin Inhibitor-Induced Chronic Nephrotoxicity in Chinese Liver Transplant Recipients. |
| Q34519960 | Decreased GFR estimated by MDRD or Cockcroft-Gault equation predicts incident CVD: the strong heart study |
| Q42777311 | Determinants of intravascular resistance in Indian diabetic nephropathy patients: a hospital-based study. |
| Q34021345 | Development and validation of GFR-estimating equations using diabetes, transplant and weight |
| Q33583018 | Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis |
| Q36441616 | Diabetic nephropathy: What does the future hold? |
| Q38088843 | Diagnostic biomarkers of diabetic nephropathy. |
| Q36210022 | Diagnostic value of cystatin C for diagnosis of early renal damages in type 2 diabetic mellitus patients: The first experience in Iran |
| Q26741494 | Early detection of diabetic kidney disease: Present limitations and future perspectives |
| Q36326391 | Early nephropathy in type 1 diabetes: a new perspective on who will and who will not progress |
| Q37418807 | Early nephropathy in type 1 diabetes: the importance of early renal function decline |
| Q37403180 | Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria. |
| Q35692447 | Early renal function decline in type 2 diabetes |
| Q34983153 | Effect of enhanced external counterpulsation treatment on renal function in cardiac patients |
| Q34292912 | Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial |
| Q36667186 | Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease |
| Q87786140 | Effects of a Multicomponent Life-Style Intervention on Weight, Glycemic Control, Depressive Symptoms, and Renal Function in Low-Income, Minority Patients With Type 2 Diabetes: Results of the Community Approach to Lifestyle Modification for Diabetes |
| Q35189566 | Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study |
| Q90288079 | Estimated GFR: time for a critical appraisal |
| Q51906074 | Estimated glomerular filtration rate (eGFRCystC) from serum cystatin C shows strong agreement with iohexol clearance in patients with low GFR. |
| Q35278435 | Estimating GFR in adult patients with hematopoietic cell transplant: comparison of estimating equations with an iohexol reference standard |
| Q41886073 | Estimating glomerular filtration rate in diabetes using serum cystatin C. |
| Q51940505 | Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. |
| Q47929159 | Estimation of Glomerular Filtration Rate in Elderly Chronic Kidney Disease Patients: Comparison of Three Novel Sophisticated Equations and Simple Cystatin C Equation |
| Q37826129 | Estimation of glomerular filtration rate: what are the pitfalls? |
| Q50784155 | Estimation of renal function in patients with eating disorders. |
| Q40940267 | Evaluation of Serum Spondin 2 Levels in the Different Stages of Type 2 Diabetic Nephropathy |
| Q51463577 | Evaluation of creatinine, cystatin C and eGFR by different equations in professional cyclists during the Giro d'Italia 3-weeks stage race. |
| Q35123425 | Evolution of renal hyperfiltration and arterial stiffness from adolescence into early adulthood in type 1 diabetes |
| Q47548352 | Expression of cystatin C in the female reproductive tract and its effect on human sperm capacitation |
| Q39112475 | Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment |
| Q51529199 | Glomerular filtration rate estimation in patients with type 2 diabetes: creatinine- or cystatin C-based equations? |
| Q37901050 | Glomerular filtration rate estimation: performance of serum cystatin C-based prediction equations |
| Q37591529 | Glomerular filtration rate measurement and prediction equations. |
| Q35278672 | Glomerular hyperfiltration and albuminuria in children with sickle cell anemia |
| Q37051743 | HIV viremia and changes in kidney function |
| Q34538110 | Heritability of measures of kidney disease among Zuni Indians: the Zuni Kidney Project |
| Q33873169 | High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up |
| Q46119552 | Higher Cystatin C Levels Are Associated With Neurocognitive Impairment in Older HIV+ Adults |
| Q37106389 | Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: the CACTI study |
| Q35020305 | Improving prognosis estimation in patients with heart failure and the cardiorenal syndrome |
| Q37051619 | In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. |
| Q36844894 | Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes. |
| Q28387350 | Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA) |
| Q37531889 | Integrating albuminuria and GFR in the assessment of diabetic nephropathy |
| Q42587254 | Is Cystatin C an Important Prognostic Marker Independent of Renal Function? |
| Q79634086 | Is elevated cystatin C a predictor of cardiovascular risk in elderly people without chronic kidney disease? |
| Q34983087 | Kidney function and clinical recommendations of drug dose adjustment in geriatric patients |
| Q46783054 | Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study |
| Q35576334 | Kidney function decline in the elderly: impact of lipoprotein-associated phospholipase A(2). |
| Q44681760 | Kidney function estimating equations in patients with chronic kidney disease |
| Q37117112 | Linkage analysis of glomerular filtration rate in American Indians. |
| Q34751900 | Longitudinal association of depressive symptoms with rapid kidney function decline and adverse clinical renal disease outcomes. |
| Q37670325 | Longitudinal changes in estimated and measured GFR in type 1 diabetes |
| Q33819382 | Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis |
| Q37322729 | Neutrophil gelatinase-associated lipocalin in kidney transplantation is an early marker of graft dysfunction and is associated with one-year renal function. |
| Q29417066 | New susceptibility loci associated with kidney disease in type 1 diabetes |
| Q37861885 | Pathophysiology, prevention and management of chronic kidney disease in the hypertensive patient with diabetes mellitus. |
| Q36624746 | Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction and Switch-2-Year Follow-Up. |
| Q31112191 | Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes. |
| Q39212398 | Precision Medicine Approaches to Diabetic Kidney Disease: Tissue as an Issue |
| Q33591588 | Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). |
| Q45351899 | Protective effects of reducing renal ischemia-reperfusion injury during renal hilar clamping: use of allopurinol as a nephroprotective agent |
| Q34330236 | Proteomic discovery of diabetic nephropathy biomarkers |
| Q35025494 | Race differences in prevalence of chronic kidney disease among young adults using creatinine-based glomerular filtration rate-estimating equations |
| Q35108889 | Racial and ethnic differences in kidney function decline among persons without chronic kidney disease |
| Q35133148 | Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis |
| Q33646576 | Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C. |
| Q36499617 | Reduced cystatin C-estimated GFR and increased creatinine-estimated GFR in comparison with iohexol-estimated GFR in a hyperthyroid patient: a case report |
| Q33905277 | Relationship between cystatin C and coronary artery atherosclerosis progression differs by type 1 diabetes |
| Q34699197 | Risks of rapid decline renal function in patients with type 2 diabetes |
| Q42711742 | Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats |
| Q37042111 | Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes. |
| Q47579396 | Serum cystatin C is associated with subclinical atherosclerosis in patients with type 2 diabetes: A retrospective study |
| Q35661440 | Serum cystatin C reflects the progress of albuminuria |
| Q48214651 | Short-term use of adaptive servo ventilation improves renal function in heart failure patients with sleep-disordered breathing |
| Q51306806 | Simple cystatin C formula compared to serum creatinine-based formulas for estimation of glomerular filtration rate in patients with mildly to moderately impaired kidney function. |
| Q51563499 | Simple cystatin C formula compared to sophisticated CKD-EPI formulas for estimation of glomerular filtration rate in the elderly. |
| Q36248461 | Simple cystatin C formula for estimation of glomerular filtration rate in overweight patients with diabetes mellitus type 2 and chronic kidney disease |
| Q47586080 | Sodium bicarbonate infusion in patients undergoing orthotopic liver transplantation: a single center randomized controlled pilot trial |
| Q37064114 | Temporal trends in the prevalence of diabetic kidney disease in the United States |
| Q35859349 | The Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) equation does not improve the underestimation of Glomerular Filtration Rate (GFR) in people with diabetes and preserved renal function |
| Q90333711 | The Error of Estimated GFR in Type 2 Diabetes Mellitus |
| Q43588428 | The GFR and GFR decline cannot be accurately estimated in type 2 diabetics |
| Q37101044 | The Protective Effects of Cobra Venom from Naja naja atra on Acute and Chronic Nephropathy |
| Q38121765 | The applicability of eGFR equations to different populations. |
| Q37464712 | The association of pioglitazone and urinary tract disease in type 2 diabetic Taiwanese: bladder cancer and chronic kidney disease |
| Q34092120 | The association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family Study |
| Q37760090 | The clinical significance of hyperfiltration in diabetes |
| Q38071252 | The effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials. |
| Q37256685 | The efficacy of the cystatin C based glomerular filtration rate in the estimation of safe contrast media volume |
| Q36740058 | The relationship of ADC values of renal parenchyma with CKD stage and serum creatinine levels |
| Q30423005 | Therapeutic Modalities in Diabetic Nephropathy: Future Approaches |
| Q37022037 | Trajectories of kidney function decline in young black and white adults with preserved GFR: results from the Coronary Artery Risk Development in Young Adults (CARDIA) study |
| Q38549960 | Update on Estimation of Kidney Function in Diabetic Kidney Disease. |
| Q37126287 | Update on cystatin C: incorporation into clinical practice |
| Q46017056 | Use of cystatin C-based estimations of glomerular filtration rate in patients with type 2 diabetes. |
| Q54253584 | miRNA profiling for the early detection and clinical monitoring of diabetic kidney disease. |
Search more.